AVR 0.99% $15.30 anteris technologies ltd

Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular, page-18

  1. 1,225 Posts.
    lightbulb Created with Sketch. 249
    So pleased for holders. I was convinced you'd done your dough. Obviously still a spec but geez it was a 100% loss if this deal didn't happen so it's a wonderful result for holders in that sense. SP a bit nowhere but better than losing the lot! V happy to have been wrong.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.